Recent Posts
Connect with:
Sunday / June 23.
HomeminewsPresmed Expands into Tasmania

Presmed Expands into Tasmania

Presmed Australia (PMA) has taken a minority shareholding in the Devonport Eye Hospital (DEH) and the practices of North West Eye Surgeons (NWES). DEH is a one theatre ophthalmic specialty day surgery opened in 2014 with co-located consulting rooms of NWES, and additional consulting rooms in Burnie.

NWES, which has been servicing Tasmania’s north west coast community for over 50 years, has three ophthalmologists, supported by a team of ophthalmic experts. Over the next few years, PMA plans to increase its shareholding until it becomes the majority owner of both businesses.

Over the next few years, PMA plans to increase its shareholding until it becomes the majority owner of both businesses

In a statement issued PMA said, “This is an exciting opportunity in that it adds another specialised day hospital to the PMA Group, in addition to its expanding practice acquisition segment. The mutual benefits of both businesses in a fast-growing location with strong market share bodes well for PMA’s continued growth. This is PMA’s first purchase outside of NSW and will be the sixth facility in our group and second consulting practice acquisition; which includes Chatswood Private Hospital, Epping Surgery Centre, Central Coast Day Hospital, Madison Day Surgery and Metwest Surgical, incorporating the consulting practice of Metwest Eye Centre.”

PMA’s Chief Executive Officer, Mr Roger Cronin said, “As with PMA’s other facilities, DEH and NWES will emphasise supporting and working with doctors and specialist staff to meet the ophthalmic needs of the community. Patients will be able to look forward to first class facilities and meticulous level of care that the PMA Group of hospitals and consulting practices are known for.”

As part of the PMA Group, DEH will have access to the many advantages available to businesses under its umbrella. These include having access to PMA’s expert industry knowledge, Group health fund negotiations and corporate buying power, clinical and corporate quality and risk management programs including accreditation, financial and business acumen including cost efficiencies, and dedicated corporate staff as well as the strong value of the trusted PMA brand.